Rising prevalence of chronic diseases, favorable reimbursement scenario and government support, and the increasing number of regulatory approvals resulting in the increased adoption among patients. The global injection pen market is expected to reach $41.38 Billion by 2022 from $30.97 Billion in 2017, at a CAGR of 6.0%. Segments The market is segmented on the basis of type, therapy, end user, and region. Based on type, the market is segmented … Continue reading Global Injection Pen Market Dominated by Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France)